522 Studies Now Enrolling
Clinical Trials of Multivalent Opioid Vaccine Components
Clinical Trials of Multivalent Opioid Vaccine Components
| Sponsor: | National Institute on Drug Abuse |
| Enrolling: | Male and Female Patients |
| Study Length: | 42 Weeks |
| Clinic Visits: | 42 |
| IRB Number: | 7712 |
| U.S. Govt. ID: | NCT04458545 |
| Contact: | Rachel Luba: 646-774-6243 / rrl2117@cumc.columbia.edu |
Additional Study Information:
Healthy heroin users (men and women, ages 18-59) are needed for an inpatient and outpatient study investigating medication effects at the NY State Psychiatric Institute. Earn approximately $7,250. Call the Substance Use Research Center at (646)-774-6243.
Do You Qualify?
| Are you currently using heroin or other opioids? | Yes | No |
| Are you between 18 and 59 years old? | Yes | No |
| Are you pregnant or breastfeeding? | Yes | No |
| Have you ever used opioids intranasally (through your nose)? | Yes | No |
| Are you willing to receive an experimental vaccine for opioid use disorder? | Yes | No |